Results 281 to 290 of about 120,733 (325)

Albuminuria in Type 2 Diabetes and Risk of Cardiorenal Outcomes. [PDF]

JACC Adv
Parveen S, Malmborg M, Arulmurugananthavadivel A, Carlson N, Andersson C, Andersen CF, Jensen J, Anjum DZ, Elmegaard M, Eroglu T, Fosbøl E, Gislason G, Køber L, Schou M.   +13 more
europepmc   +1 more source

Diabetic kidney disease, biomarkers, and finerenone

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Diabetic kidney disease (DKD), the leading cause of kidney failure worldwide, is associated with an increased risk of cardiovascular disease (CVD). A complex pathobiology involving hemodynamic, metabolic, and immune dysregulation promotes inflammatory and fibrotic pathways that contribute to kidney disease progression and CVD in individuals ...
Ashish Verma, Ashish Upadhyay
wiley   +1 more source

A J-shaped link between body roundness index and albuminuria in U.S. adults: insights from NHANES 2005-2020. [PDF]

Ren Fail
Lei X, Peng X, Liu X, Li Y.
europepmc   +1 more source

Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomised double‐blind, placebo‐controlled trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The precise mechanism of sodium glucose co‐transporter 2 (SGLT2) inhibitor on reno‐protective effect has been still unclear. In this study, we hypothesised that SGLT2 inhibitor prevents diabetic kidney disease via reduction of hypoxia‐induced factors.
Hisashi Makino, Masato Kasahara, Ryuzo Takashima, Shu Kasama, Naoki Ozu, Hyohun Park, Qingxing Chen, Kazuhiko Tsuruya, Mayu Tochiya, Yoko Omura‐Ohata, Tamiko Tamanaha, Michio Noguchi, Takeshi Aiba, Fumiki Yoshihara, Kiminori Hosoda   +14 more
wiley   +1 more source

Real-World Data: Critical Evidence to Better Understanding Kidney Benefits with Sodium-Glucose Cotransporter 2 Inhibitors. [PDF]

Kidney360
Neumiller JJ, Tuttle KR.
europepmc   +1 more source

SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Randomized controlled trials on sodium‐glucose cotransporter 2 (SGLT2) inhibitors have yielded inconsistent findings regarding mortality benefits. It remains unclear whether, and in which subgroups, SGLT2 inhibitors confer survival benefits in older adults with diabetic kidney disease (DKD).
Tatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, Yuta Suzuki, Toshiyuki Ko, Kazuki Aoyama, Takashin Nakayama, Yuya Kimura, Katsuhiko Fujiu, Norifumi Takeda, Hiroyuki Morita, Takashi Yokoo, Koichi Node, Masaomi Nangaku, Norihiko Takeda, Hideo Yasunaga, Kaori Hayashi   +16 more
wiley   +1 more source

Evaluation of the Relationship Between Albuminuria and Triglyceride Glucose Index in Patients with Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study. [PDF]

Medicina (Kaunas)
Yilmaz O, Erinc O.
europepmc   +1 more source

Risk of Chronic Kidney Disease and Implications in Patients with Atrial Fibrillation for the Development of Major Adverse Cardiovascular Events with Machine Learning. [PDF]

Med Sci (Basel)
Moltó-Balado P, Clua-Espuny JL, Tarongi-Vidal C, Barrios-Carmona P, Alonso-Barberán V, Balado-Albiol MT, Simeó-Monzó A, Canela-Royo J, Del Barrio-González A.   +8 more
europepmc   +1 more source

Dysregulation of Niacin-Derived NAD⁺ Salvage Pathway Markers (CD38, NAMPT, SIRT1) Across Albuminuria Stages in Type 2 Diabetes. [PDF]

Medicina (Kaunas)
Huwaimel B, Alqarni S, Abouzied AS, Alghubayshi A, Alotaibi T, Elshafei A, Yassien M, Nasr M, Khidr EG.   +8 more
europepmc   +1 more source